Abstract
Actinomycetes are one of the most efficient groups of secondary metabolite producers and are very important from an industrial point of view. Among its various genera, Streptomyces, Saccharopolyspora, Amycolatopsis, Micromonospora and Actinoplanes are the major producers of commercially important biomolecules. Several species have been isolated and screened from the soil in the past decades. Consequently the chance of isolating a novel actinomycete strain from a terrestrial habitat, which would produce new biologically active metabolites, has reduced. The most relevant reason for discovering novel secondary metabolites is to circumvent the problem of resistant pathogens, which are no longer susceptible to the currently used drugs. Existence of actinomycetes has been reported in the hitherto untapped marine ecosystem. Marine actinomycetes are efficient producers of new secondary metabolites that show a range of biological activities including antibacterial, antifungal, anticancer, insecticidal and enzyme inhibition. Bioactive compounds from marine actinomycetes possess distinct chemical structures that may form the basis for synthesis of new drugs that could be used to combat resistant pathogens.
Article PDF
Similar content being viewed by others
References
Bull AT (2004) Microbial diversity and biosprospecting. ASM Press
Berdy J (2005) Bioactive microbial metabolites. J Antibiot (Tokyo) 58:1–26
Mann J (2001) Natural products as immunosuppressive agents. Nat Prod Rep 18:417–430
Pecznska Czoch W and Mordaski M (1988) Actinomycetes in biotechnology. Academic Press London, pp 219–283
Reeves AR, Post DA and Boom TJV (1998) Physical genetic map of the erythromycin producing organism Saccharopolyspora erythraea. Microbiology 144:2151–2159
Madduri K, Waldron C and Merlo DJ (2001) Rhamnose biosynthesis pathway supplies precursors for primary and secondary metabolism in Saccharopolyspora spinosa. J Bacteriol 183:5632–5638
Wanq L, Yun BS, Geirge NP, Wendt-Pienkowski E, Galm U, Oh TJ, Couqhlin JM, Zhang G, Tao M and Shen B (2007) Glycopeptide antitumor antibiotic zorbamycin from Streptomyces flavoviridis ATCC 21892: strain improvement and structure elucidation. J Nat Prod 70:402–406
Okami Y, Tazaki T, Katumata S, Honda K, Suzuki M and Umezawa H (1959) Studies on Streptomyces kanamyceticus, producer of kanamycin. J Antibiot (Tokyo) 12:252–256
Zhou J, Sun C, Wanq N, Gao R, Bai S, Zhenq H, You X and Li R (2006) Preliminary report on the biological effects of space flight on the producing strain of a new immunosuppressant kanglemycin C. J Ind Microbiol 33:707–712
Lomovskaya N, Fonstein L, Ruan X, Stassi D, Katz L and Hutchinson CR (1997) Gene disruption and replacement in the rapamycin producing Streptomyces hygroscopicus strain ATCC 29253. Microbiology 143:875–883
Steinrauf LK, Pinkerton M and Chamberlin JW (1968) The structure of nigericin. Biochem Biophys Res Commun 33:29–31
Wu K, Chunq L, Revill WP, Katz L and Reeves CD (2000) The FK520 gene cluster of Streptomyces hygroscopicus var. ascomyceticus (ATCC 14891) contains genes for biosynthesis of unusual polyketide extender units. Gene 251:81–90
Lam KS, Hesler GA, Mattei JM, Mamber SW, Forenza S and Tomita K (1990) Himastatin, a new antitumor antibiotic from Streptomyces hygrocopicus. I. Taxonomy of producing organism, fermentation and biological activity. J Antibiot (Tokyo) 43:956–960
Jian X, Pang X, Yu Y, Zhou X and Deng Z (2006) Identification of genes necessary for jinggangmycin biosynthesis from Streptomyces hygroscopicus 10–22. Antonie van Leeuwenhoek 90:29–39
Petkovic H, Cullum J, Hranueli D, Hunter IS, Peric Concha N, Pigac J, Thamchaipenet A, Vujaklija D and Long PF (2006) Genetics of Streptomyces rimosus, the oxytetracycline producer. Microbiol Mol Biol Rev 70:704–728
Caffrey P, Lynch S, Flood E, Finnan S and Oliynyk M (2001) Amphotericin biosynthesis in Streptomyces nodosus: deductions from analysis of polyketide synthase and late genes. Chem Biol 8:71–723
Hu Y and Floss HG (2004) Further studies on the biosynthesis of the manumycin type antibiotic asukamycin and the chemical synthesis of protoasukamycin. J Am Chem Soc 126:3837–3844
Malanicheva IA, Kozmian LI, Dudnik IuV, Stromilova LI and Novozhenov MIu (1992) Protoplast fusion in Streptomyces fradiae strains producing neomycin and tylosin. Antibiot Khimioter 37:3–7
Decker H and Haag S (1995) Cloning and characterization of a polyketide synthase gene from Streptomyces fradiae Tu2717, which carries the genes for biosynthesis of the anglucycline antibiotic urdamycin A and a gene probably involved in its oxygenation. J Bacteriol 177:6126–6136
Rorers TO and Birnbaum J (1974) Biosynthesis of fosfomycin by Streptomyces fradiae. Antimicrob Agents Chemother 5:121–132
Perez-Zuniqua FJ, Seco EM, Cuesta T, Dequenhardt F, Rohr J, Vallin C, Iznaqa Y, Perez ME, Gonzalez L and Malpartida F (2004) CE-108, a new macrolide tetraene antibiotic. J Antibiot (Tokyo) 57:197–204
Seco EM, Zuniga FJP, Rolon MS and Malpartida F (2004) Starter unit choice determines the production of two tetraene macrolides, rimocidin and CE-108, in Streptomyces diastaticus var. 108. Chem Biol 11:357–366
Kamazawa S, Asami Y, Awane K, Ohtani H, Fukuchi C, Mikawa T and Hayase T (1994) Structural studies of new macrolide antibiotics, shurimycins A and B. J Antibiot ( Tokyo) 47:688–96
Piraee M, White RL and Vining LC (2004) Biosynthesis of the dichloroacetyl component of chloramphenicol in Streptomyces venezuelae ISP5230 genes required for halogenation. Microbiology 15:85–94
Krishna PSM, Venkateshwarlu G and Rao LY (1998) Studies on fermentative production of rifamycin using Amycolatopsis mediterranei. J Microbiol Biotechnol 14:689–691
Hughes RA, Thompson SP, Alcaraz L and Moody CJ (2004) Total synthesis of the thiopeptide amythiamicin D. Chem Commun 946–948
Rhee KH (2002) Isolation and characterization of Streptomyces sp. KH614 producing anti-VRE (vancomycin-resistant enterococci) antibiotics. J Gen Appl Microbiol 48:321–327
Schully Kl, Wang J and Pettis GS (2006) Further molecular analysis of a bacteriocin produced by the sweet potato pathogen Streptomyces ipomoeae that shows inter strain inhibition. Phytopathology 96:105
Nomi R (1963) Streptomycin formation by intact mycelium of Streptomyces griseus. J Bacteriol 86:1220–1230
Perkins JB, Guterman SK, Howitt CL, Williams II VE and Pero J (1990) Streptomyces genes involved in biosynthesis of the peptide antibitotic valinomycin. J Bacteriol 172:3108–3116
Stroshane RM, Chan JA, Rubalcaba EA, Garretson AL, Aszalos AA and Roller PP (1979) Isolation and structure elucidation of novel griseorhodin. J Antibiot (Tokyo) 32:197–204
Warnick-Pickle DJ, Byrne KM, Pandey RC and White RJ (1981) Fredericamycin A, a new antitumor antibiotic. II. Biological properties. J Antibiot (Tokyo) 34:1402–1407
Yamaquchi H, Sato S, Yoshida S, Takada K, Itoh M, Seto H and Otake N (1986) Capuramycin, a new nucleoside antibiotic. Taxonomy, fermentation, isolation and characterization. J Antibiot (Tokyo) 39:1047–1053
Bruntner C, Binder T, Pathom-aree W, Goodfellow M, Bull AT, Potterat O, Puder C, Horer S, Schmid A, Bolek W, Wagner K, Mihm G and Fiedler HP (2005) Frigocyclinone, a novel angucyclinone antibiotic produced by a Streptomyces griseus strain from Antartica. J Antibiot (Tokyo) 58:346–349
Pojer F, Wemakor E, Kammerer B, Chen H, Walsh CT, Li SM and Heide L (2003) CloQ, a prenyltransferase involved in clorobiocin biosynthesis. Biochem 100:2316–2321
Sun Y, Zhou X, Liu J, Bao K, Zhang G, Tu G, Kieser T and Deng Z (2002) Streptomyces nanchangensis a producer of the insecticidal polyether antibiotic nanchangmycin and the antiparasitic macrolide meilingmycin, contains multiple polyketide gene clusters. Microbiology 148:361–371
Malkova IV, Borisova OK, Pavlova MV, Zemlianitskaia EP and Serquuva TI (1991) In vitro activity of a new glycopeptide antibiotic eremomycin in relation to obligate anaerobic gram positive bacteria. Antibiot Khimioter 36:17–20
Trenin AS, Fedorova GB, Laiko AV and Dudnik IuV (2001) Increase in eremomycin production by regeneration and UV-irradiation of Amycolatopsis orientalis subsp. eremomycini protoplasts. Antibiot Khimioter 46:6–11
Luo A, Gao C, Song Y, Tan H and Liu Z (1998) Biological responses of a Streptomyces strain producing nikkomycin to space flight space. Med Eng (Beijing) 11:411–414
Weitnauer G, Muhlenweg A, Trefzer A, Hoffmeister D, Submuth RD, Jung G, Welzel K, Vente A, Girreser U and Bechthold A (2001) Biosynthesis of the orthosomycin antibiotic avilamycin A: Deductions from the molecular analysis of the avibiosynthetic gene cluster of Streptomyces viridochromogenes Tu57 and production of new antibiotics. Chem Biol 8:569–581
Iqarashi M, Hayashi C, Homma Y, Hattori S, Kinoshita N, Hamada M and Takeuchi T (2000) Tubelactomicin A, a novel 16-membered lactone antibiotic from Nocardia sp. I. Taxonomy, production, isolation and biological properties. J Antibiot (Tokyo) 53:1096–1101
Theriault RJ, Rasmussen RR, Kohl WL, Prokop JF, Hutch TB and Barlow GJ (1986) Benzanthrins A and B, a new class of quinone antibiotics. I. Discovery, fermentation and antibacterial activity. J Antibiot (Tokyo) 39:1509–1514
Omura S (1986) Philosophy of new drug discovery. Microbiol Rev 50:259–279
Ylihonko K, Tuikkanen J, Jussila S, Cong L and Mantsala P (1996) A gene cluster involved in nogalamycin biosynthesis from Streptomyces nogalater: sequence analysis and complementation of early block mutations in the anthracycline pathway. Mol Gen Genet 251:113–120
Raty K, Hautala A, Torkkell S, Kantola J, Mantsala P, Hakala J and Ylihonko K (2002) Characterization of mutations in aclacinomycin, a non-producing Streptomyces galilaeus strains with altered glycosylation patterns. Microbiology 148:3375–3384
Nakata M, Saito M, Inouye Y, Nakamura S, Hayakawa Y and Seto H (1992) A new anthracycline antibiotic, cinerubin R. Taxonomy, structural elucidation and biological activity. J Antibiot (Tokyo) 45:1599–1608
Samain D, Cook JC and Rinehart KL (1982) Structure of scopafungin, a potent nonpolyene antifungal antibiotic. J Am Chem Soc 104:4129–4141
Ikeda H, Inoue M and Satoshi O (1982) Improvement of macrolide antibiotic producing Streptomycete strains by the regeneration of protoplasts. J Antibiot (Tokyo) 36:283–288
Lagard VC, Blanc V, Gil P, Naudin L, Lorenzon S, Famechon A, Jacques NB, Crouzet J and Thibaut D (1997) Pristinamycin I biosynthesis in Streptomyces pristinaespiralis: molecular characterization of the first two structural peptide synthetase genes. J Bacteriol 179:705–713
Kinashi H, Mori E, Hatani A and Nimi O (1994) Isolation and characterization of linear plasmids from lankacidin producing Streptomyces species. J Antibiot (Tokyo) 47:1447–1455
Konoshenko GI, Avraleva IV, Anisova LN and Orlova TI (1994) Biologically active substances by a number of strains of the actinomycin C producer Streptomyces chyrsomallus. Antibiot Khimioter 39:22–25
Jingsong YE, Dickens ML, Plater R, Yun LI, Jessica L and Strohl WR (1994) Isolation and sequence analysis of polyketide synthase genes from the daunomycin producing Streptomyces sp. strain C5. J Bacteriol 176:6270–6280
Hara O and Hutchinson CR (1992) A macrolide 3-O-acyltransferase gene from the midecamycin producing species Streptomyces mycarofaciens. J Bacteriol 174: 5141–5144
Ikeda H, Nonomiya T, Usami M, Ohta T and Omura S (1999) Organization of the biosynthetic gene cluster for the polyketide anthelmintic macrolide avermectin in Streptomyces avermitilis. Biochem 96:9509–9514
Ikeda H and Omura S (1995) Control of avermectin biosynthesis in Streptomyces avermitilis for the selective production of a useful component. J Antibiot (Tokyo) 48:549–562
Iquarashi M, Kinoshita N, Ikeda T, Kameda M, Hamada M and Takeuchi T (1997) Resormycin, a novel herbicidal and antifungal antibiotic produced by a strain of Streptomyces platensis. I. Taxonomy, production, isolation and biological properties. J Antibiot (Tokyo) 50:1020–1025
Kawakami Y, Matsuwaka S, Otani T, Kondo H and Nakamura S (1978) Ileumycin, a new antibiotic against Glomerella cingulata. J Antibiot (Tokyo) 31:112–116
Mao Y, Varoglu M and Sherman DH (1999) Molecular characterization and analysis of the biosynthetic gene cluster for the antitumor antibiotic Mitomycin C from Streptomyces lavendulae NRRL 2564. Chem Biol 6:251–263
Johnson LE and Dietz A (1969) Lomofungin, a new antibiotic produced by Streptomyces lomondensis sp. Appl Microbiol 17:755–759
Johnson LE and Dietz A (1968) Kalafungin, a new antibiotic produced by Streptomyces tanashiensis strain kala. Appl Microbiol 16:1815–1821
Cassinelli G, Cotta E, D’Amico G, Della Bruna C, Grein A, Mazzoleni R, Ricciardi ML and Tintinelli R (1970) Thiamycins, new anthelmintic and antiprotozoal antibiotics produced by Streptomyces michiganensis var. amylolyticus var. nova. Arch Mikrobiol 70:197–210
Bruna CD, Ricciardi ML and Sanfilippo A (1973) Axenomycins, new cestocidal antibiotics. Antimicrob Agents Chemother 3:708–710
Wu RY, Yanq LM, Yokoi T and Lee KH (1988) Neihumicin, a new cytotoxic antibiotic from Micromonospora neihuensis. I. The producing organism, fermentation, isolation and biological properties. J Antibiot (Tokyo) 41:481–487
Ohta T and Haseqawa M (1993) Analysis of the self defense gene (fmrO) of a fortimicin A (astromicin) producer, Micromonospora olivasterospora: comparison with other aminoglycoside-resistance encoding genes. Gene 127:63–69
Escalante L, Gonzalez R, Obregon AM and Sanchez S (1992) Carbon catabolite regulation of gentamicin formation. J Antibiot (Tokyo) 45:465–469
Ross A and Schugerl K (2005) Tetracycline production by Streptomyces aureofaciens: the time lag of production. Appl Microbiol Biotechnol 29:174–180
Gauze GF, Preobrazhenskaia TP, Ivanitskaia LP and Kovalenkova VK (1960) Synthesis of new antibiotic monomycin by Actinomyces circulatus var. monomycini cultures. Antibiotiki 5:3–6
Malanicheva IA, Kozmian LI, Dudnik IuV, Florova GIa and Orekhov AV (1992) Comparative study of Streptomyces producer of aminoglycoside antibiotics, monomycin and kanamycin and the strain 344 obtained by fusion of their protoplasts by the method of restrictive total DNA fingerprinting. Antibiot Khimioter 37:5–7
Kumaqai K, Fukui A, Tanaka S, Ikemoto M, Moriquchi K and Nabeshima S (1993) PC-766B, a new macrolide antibiotic produced by Nocardia brasiliensis. II. Isolation, physico-chemical properties and structures elucidation. J Antibiot (Tokyo) 46:1139–1144
Xia H, Wanq Y, and Sun J (1994) Characterization of polyketide ketoreductase gene (MPKR) from midecamycin producing strain (Streptomyces mycarofaciens 1748). Chin J Biotechnol 10:169–178
Schlegel L, Merad B, Rostane H, Broc V and Bouvet A (2001) In vitro activity of midecamycin diacetate, a 16-membered macrolide, against Streptococcus pyogenes isolated in France, 1995–1999. Clin Microbiol Infect 7:362–366
Karwowski JP, Jackson M, Maus ML, Kohl WL, Humphrey PE and Tillis PM (1991) Dunaimycins, a new complex of spiroketal 24-membered macrolides with immunosuppressive activity. I. Taxonomy of the producing organisms, fermentation and antimicrobial activity. J Antibiot (Tokyo) 44: 1312–1317
Mitchell JI, Loqan PG, Cushinq KE and Ritchie DA (1990) Novobiocin-resistance sequences from the novobiocin producing strain Streptomyces niveus. Mol Microbiol 4: 845–849
Naumova IB, Diqumbai K, Potekhina NV, Shashkov AS and Terekhova LP (1986) Teichoic acid from the cell wall of Actinomadura carminata a producer of the antibiotic carminomycin. Bio Org Khim 12:670–678
Terekhova LP, Galatenko OA, Preobrazhenskaia TP, Tolstykh IV, Ol’Khovatova OL, Malkina ND and Rubtsova EV (1991) Actinomadura species as antibiotic producers. Antibiot Khimioter 36:3–5
Ashton RJ, Keniq MD, Luk K, Planterose DN and Scott-Wood G (1990) MM46115, a new antiviral antibiotic from Actinomadura pelletieri. Characteristics of the producing cultures, fermentation, isolation, physiochemical and biological properties. J Antibiot (Tokyo) 43:1387–1393
Nishiyama Y, Suqawara K, Tomita K, Yamamoto H, Kamei H and Oki T (1993) Verucopeptin, a new antitumor antibiotic active against B16 melanoma. I. Taxonomy, production, isolation, physico-chemical properties and biological activity. J Antibiot (Tokyo) 46:921–927
Abe N, Nakakita Y, Nakamura T, Enoki N, Uchida H and Munekata M (1993) Novel antitumor antibiotics, saptomycins. I. Taxonomy of the producing organism, fermentation, HPLC analysis and biological activities. J Antibiot (Tokyo) 46:1530–1535
Abe N, Nakakita Y, Nakamura T, Enoki N, Uchida H, Takeo O and Munekata M (1993) Novel cytocidal compounds, oxapropalines from Streptomyces sp. G324 producing lavendamycin. I. Taxonomy of the producing organism, fermentation, isolation and biological activities. J Antibiot (Tokyo) 46:1672–1677
Balitz DM, Bush JA, Bradner WT, Doyle TW, Herron FAO and Nettleton DE (1982) Isolation of lavendamycin — A new antibiotic from Streptomyces lavendulae. J Antibiot (Tokyo) 3:259–265
Arai T, Yazawa K, Mikami Y, Kubo A and Takahashi K (1976) Isolation and characterization of satellite antibiotics mimosamycin and chlorocarcins from Streptomyces lavendulae, streptothricin source. J Antibiot (Tokyo) 4:398–407.
Komori T, Ezaki ME, Kohsaka M, Aoki H and Imanaka H (1985) Lavendomycin, a new antibiotic. I. Taxonomy, isolation and characterization. J Antibiot (Tokyo) 38:691–698
Umezawa I, Tronouet C, Funayama S, Okada K and Komiyama K (1985) A novel antibiotic, sohbumycin. Taxonomy, fermentation, isolation and physico-chemical and biological characteristiocs. J Antibiot (Tokyo) XXXVIII:967–971
Ishibashi M, Funayama S, Anraku Y, Komiyama K and Omura S (1991) Novel antibiotics furaquinocins C, D, E, F, G and H. J Antibiot (Tokyo) 44:390–395
Karwowski JP, Jackson M, Theriault RJ, Prokop JF, Maus ML, Hansen CF and Hensey DM (1988) Arizonins, a new complex of antibiotics related to kalafungin. I. Taxonomy of the producing culture, fermentation and biological activity. J Antibiot (Tokyo) 9:1205–1211
Jackson M, Karwowski JP, Theriault RJ, Fernandes PB, Semon RC and Kohl WL (1987) Coloradocin, an antibiotic from a new Actinoplanes. I. Taxonomy, fermentation and biological properties. J Antibiot (Tokyo) 40:1375–1382
Parenti F, Beretta G, Berti M and Arioli V (1978) Teichomycins, new antibiotics from Actinoplanes techomyceticus nov. sp. I. Description of the producer strain, fermentation studies and biological properties. J Antibiot (Tokyo) XXXI:276–283
Parenti F, Pagani H and Beretta G (1975) Lipiarmycin, a new antibiotic from Actinoplanes. I. Description of the producer strain and fermentation studies. J Antibot (Tokyo) 4:247–252
Itoh Y, Torikata A, Katayama C, Haneishi T and Arai M (1981) Candiplanecin, a new antibiotic from Ampullariella regularis subsp. mannitophila subsp. nov. II. Isolation, physico-chemical characterization and biological activities. J Antibiot (Tokyo) 34:934–937
Takasawa S, Kawamoto I, Okachi R, Kohakura M, Yahashi R and Nara T (1975) A new antibiotic victomycin (XK 49-1-B-2). II. Isolation, purification and physiochemical and biological properties. J Antibiot (Tokyo) XXVIII:366–371
Pandey RC, Toussaint MW, McGuire JC and Thomas MC (1989) Maggiemycin and anhyromaggiemycin: two novel anthracyclinone antitumor antibiotics: isolation, structures, partial synthesis and biological properties. J Antibiot (Tokyo) 42:1567–1577
Tokoro Y, Isoe T and Shindo K (1999) Gilvusmycin, a new antitumor antibiotic related to CC-1065. J Antibiot (Tokyo) 52:263–268
Umezawa I, Komiyama K, Oka H, Okada K, Tomisaka S, Miyano T and Takano S (1984) A new antibiotic, kazusamycin. J Antibiot (Tokyo) 37:706–711
Komiyama K, Funayama S, Anraku Y, Ishibashi M, Takahashi Y, Kawakami T and Omura S (1991) A new antibiotic, Okicenone. I. Taxonomy, fermentation, isolation and biological characteristics. J Antibiot (Tokyo) 44:814–818
Hanada M, Kaneta K, Nishiyama Y, Hoshino Y, Konishi M and Oki T (1991) Hydramycin: a new antitumor antibiotic. Taxonomy, isolation, physico-chemical properties, structure and biological activity. J Antibiot (Tokyo) 44:824–831
Schneider A, Spath J, Mack SB and Zeeck A (1996) New cineromycins and musacins obtained by metabolite pattern analysis of Streptomyces griseoviridis (FH-S1832). II. Structure elucidation. J Antibiot (Tokyo) 49:438–446
Stephan H, Kempter C, Metzger JW, Jung G, Potterat O, Pfefferle C and Fiedler HP (1996) Kanchanamycins, a new polyol macrolide antibiotics produced by Streptomyces olivaceus Tu 4018. II. Structure elucidation. J Antibiot (Tokyo) 49:765–769
Fiedler PH, Rohr J and Zeeck A (1986) Elloramycins B, C, D, E and F: Minor congeners of the elloramycin producer Streptomyces olivaceus. J Antibiot (Tokyo) 6:856–859
Yokomizo K, Miyamoto Y, Nagao K, Kumagae E, Habib ESE, Suzuki K, Harada S and Uyeda M (1998) Fattiviracin A1, a novel antiviral agent produced by Streptomyces microflavus strain no. 2445. II. Biological properties. J Antibiot (Tokyo) 51:1035–1039
Reis SA, Moussatche N and Damaso CR (2006) FK506, a secondary metabolite produced by Streptomyces, presents a novel antiviral activity against orthopoxvirus infection in cell culture. J Appl Microbiol 100:1373–1380
Pamoukian CRD and Facciotti MCR (2004) Production of the antitumoral retamycin during continuous fermentations of Streptomyces olindensis. Biochem 39:2249–2255
Thiericke R and Zeeck A (1988) Biosynthesis of manumycin: Origin of the polyene chains. J Antibiot (Tokyo) 5: 694–696
Heinstein P (1981) Mechanism of action of granaticin: Inhibition of ribosomal RNA maturation and cell cycle specificity. J Pharm Sci 71:197–200
James PD, Edwards C and Dawson M (1991) The effects of temperature, pH and growth rate on secondary metabolism in Streptomyces thermoviolaceus grown in a chemostat. J Gen Microbiol 137:1715–1720
Recio E, Colinas A, Rumbero A, Aparicio JF and Martin JF (2004) PI factor, a novel type quorum-sensing inducer elicits pimaricin production in Streptomyces natalensis. J Biol Chem 279:41586–41593
Prikrylova V, Samoukina GV, Kandybin NV, Ujhelyiova L and Varkonda K (1992) Pesticidal activity of virginiamycins S1 and M1. Folia Microbiol (Praha) 37:386–388
Rezanka T, Vancurova I, Kristufek V, Koza T, Caslavska J, Prikrylova V and Blumauerova M (1992) Taxonomic studies of Streptomyces virginiae mutants overproducing virginiamycin M1. Folia Microbiol (Praha) 37: 105–110
Wezel GP, Krabben P, Traag BA, Keijser BJF, Kerste R, Vijgenboom E, Heijnen JJ and Kraal B (2006) Unlocking Streptomyces spp. for use as sustainable industrial production platforms by morphological engineering. Appl Environ Micobiol 72:5283–5288
Hiquashide E, Hatano K, Shibata M and Nakazawa K (1968) Enduracidin, a new antibiotic. I. Streptomyces fungicidicus No.B5477, an enduracidin producing organism. J Antibiot (Tokyo) 21:126–137
Xu M, Zhu Y, Jin Z, Wu H, Li X, Yanq Y, Jiao R, Jianq W, Wu H, Tian W, Bai X and Zha O (2006) Glycine origin of the methyl subsituent on C7’-N of octodiose for the biosynthesis of apramycin. Sci China C Life Sci 49:362–369
Remsinq LL, Gonzalez AM, Nur-e-Alam M, Fernandez-Lozano MJ, Brana AF, Rix U, Oliveira MA, Mendez C, Salas JA and Rohr J (2003) Mithramycin SK, a novel antitumor drug with improved therapeutic index, mithramycin SA and demycarosyl-mithramycin SK: three new products generated in the mithramycin producer Streptomyces argillaceus through combinatorial biosynthesis. J Am Chem Soc 125:5745–5753
Zhanq Q, Gould SJ and Zabriskie TM (1998) A new cytosine glycoside from Streptomyces griseochromogenes produced by the use of in vivo of enzyme inhibitors. J Nat Prod 61:648–651
Hu Z, Reid R and Gramajo H (2005) The leptomycin gene cluster and its heterologus expression in Streptomyces lividans. J Antibiot (Tokyo) 58:625–633
Zhu L, Ostah B, Rix U, Nur-E-Alam M, Mayers A, Luzhetskyy A, Mendez C, Salas JA, Bechthold A, Fedorenko V and Rohr J (2005) Identification of the function of gene lndM2 encoding a bifunctional oxygenase-reductase involved in the biosynthesis of the antitumor antibiotic landomycin E by Streptomyces globisporus 1912 supports the originally assigned structure for landomycinone. J Org Chem 70:631–638
Durr C, Schnell HJ, Luzhetskyy A, Murillo R, Weber M, Welzel K, Vente A and Bechthold A (2006) Biosynthesis of the terpene phenalinolactone in Streptomyces sp. Tu6071: Analysis of the gene cluster and generation of derivatives. Chem Biol 13:365–377
Uchihata Y, Ando N, Ikeda Y, Kondo S, Hamada M and Umezawa K (2002) Isolation of a novel cyclic hexadepsipeptide pipalamycin from Streptomyces as an apoptosis inducing agent. J Antibiot (Tokyo) 55:1–5
Ezaki M, Iwami M, Yamashita M, Hashimoto S, Komori T, Umehara K, Mine Y, Kohsaka M, Aoki H and Imanaka H (1985) Biphenomycin A and B, novel peptide antibiotics. I. Taxonomy, fermentation, isolation and characterization. J Antibiot (Tokyo) 38:1453–1461
Gebhardt K, Pukall R and Fiedler HP (2001) Streptocidins AD, novel cyclic decapeptide antibiotics produced by Streptomyces sp. Tu6071. I. Taxonomy, fermentation, isolation and biological activities. J Antibiot (Tokyo) 54:428–433
Zhang H, Tomodo H, Tabata N, Oohori M, Shinose M, Takahashi Y and Omura S (1999) Zelkovamycin, a new cyclic peptide antibiotic from Streptomyces sp. K96-0670. I. Production, isolation and biological activities. J Antibiot (Tokyo) 52:29–33
Gonzalez Holgado G, Castro Rodriguez J, Canedo Hernandez LM, Diaz M, Fernandes-Abalos JM, Trujillano I and Santamari RI (2002) Radamycin, a novel thiopeptide produced by Streptomyces sp. RSP9. I. Taxonomy, fermentation, isolation and biological activities. J Antibiot (Tokyo) 54:383–390
Sohda KY, Nagai K, Yamori T, Suzuki K and Tanaka A (2005) YM216391, a novel cytotoxic cyclic peptide from Streptomyces nobilis. I. Fermentation, isolation and biological activities. J Antibiot (Tokyo) 58:27–31
Toki S, Agatsuma T, Ochiai K, Saitoh Y, Ando K, Nakanishi S, Lokker NA, Giese NA and Matsuda Y (2001) RP-1776, a novel cyclic peptide produced by Streptomyces sp., inhibits the binding of PDGF to the extracellular domain of its receptor. J Antibiot (Tokyo) 54:405–414
Ubukata M, Shiraishi N, Kobinata K, Kudo T, Yamaguchi I, Osada H, Shen YC and Isono K (1995) RS-22 A, B and C: new macrolide antibiotics from Streptomyces violaceusniger. I. Taxonomy, fermentation, isolation and biological activities. J Antibiot (Tokyo) 48:289–92
Shindo K, Kamishohara M, Odagawa A, Matsuoka M and Kawai H (1993) Vicenistatin, a novel 20-membered macrocyclic lactam antitumor antibiotic. J Antibiot (Tokyo) 46:1076–1081
Bertasso M, Holzenkampfer M, Zeeck A, Stackebrandt E, Beil W and Fiedler HP (2003) Ripromycin and other polycyclic macrolactams from Streptomyces sp. Tu6239. Taxonomy, fermentation, isolation and biological activities. J Antibiot (Tokyo) 56:364–371
Igarashi M, Shida T, Sasaki Y, Kinoshita N, Naganawa H, Hamada M and Takeuchi T (1999) Vinylamycin, a new depsipeptide antibiotic from Streptomyces sp. J Antibiot (Tokyo) 52:873–879
Jacks TM, Schleim KD, Judith FR and Miller BM (1980) Cephamycin C treatment of induced enterotoxigenic colibacillosis (scours) in calves and piglets. Antibiot Chemother 18:397–402
Challis GL and Hopwood DA (2003) Synergy and contingency as driving forces for the evolution of multiple secondary metabolite production by Streptomyces species. Prod Nat Acad Sci USA 100:14555–14561
Watve MS, Tckoo R, Jog MM and Bhole BD (2001) How many antibiotics are produced by the genus Streptomyces? Arch Microbiol 176:386–390
Williams ST, Sharpe ME and Holt JG (1989) Bergey’s manual of systematic bacteriology, Vol. 4
Carlos F (2003) Multiple drug resistant bacteria. Horizon, Scientific Press
Ekwenye UN and Kazi E (2007) Investigation of plasmid DNA and antibiotic resistance in some pathogenic organism. Afr J Biotechnol 6:877–880
Lam KS (2006) Discovery of novel metabolites from marine actinomycetes. Curr Opin Microbiol 9:245–251
Fenical W and Jensen PR (2006) Developing a new resource for drug discovery: marine actinomycete bacteria. Nat Chem Biol 2:666–673
Ward AC and Bora N (2006) Diversity and biogeography of marine actinobacteria. Curr Opin Microbiol 9:279–286
Salmon CE, Magarvey NA and Sherman DH (2003) Merging the potential of microbial genetics with biological and chemical diversity: an even brighter future for marine natural product drug discovery. Nat Prod Rep 21:105–121
Helmke E and Weyland H (1983) Rhodococcus marinonascens sp. nov; an actinomycete from the sea. Int J Syst Bacteriol 34:127–138
Wu Z, Xie L, Xia G, Zhanq J, Nie Y, Hu J, Wanq S and Zhanq R (2005) A new tetrodotoxin producing actinomycete Nocardiopsis dassonvillei isolated from the ovaries of puffer fish Fugu rubripes. Toxicon 45:851–859
Stach JE, Maldonado LA, Ward AC, Goodfellow M and Bull AT (2003) New primers for the class actinobacteria: application to marine and terrestrial environments. Environ Microbiol 5:828–841
Mincer TJ, Fenical W and Jensen PR (2005) Culture dependent and culture independent diversity within the obligate marine actinomycete genus Salinispora. Appl Environ Microbiol 71:7019–7028
Tringe SG, Von Mering C, Kobayashi A, Salamov AA, Chen K, Cheng HW, Podar M, Short JM, Mathur EJ and Detter JC (2005) Comparative metagenomics of microbial communities. Science 308:554–557
Cho JY, Kwon HC, Williams PG, Jensen PR and Fenical W (2006) Azamerone, a terpenoid phthalazinone from a marine derived bacterium related to the genus Streptomyces (Actinomycetales). Org Lett 8:2471–2474
Macherla VR, Liu J, Bellows C, Teisan S, Nicholson B, Lam KS and Potts BCM (2005) Glaciapyrroles A, B and C pyrrolosesquiterpenes from a Streptomyces sp. isolated from an Alaskan marine sediment. J Nat Prod 68:780–783
Wu SJ, Fotso S, Li F, Qin S and Laatsch H (2007) Amorphane sesquiterpenes from a marine Streptomyces sp. J Nat Prod 70:304–306
Hardt IH, Jensen PR and William F (2000) Neomarinone and new cytotoxic marinone derivatives, produced by a marine filamentous bacterium (Actinomycetales). Science 41:2073–2076
William PG, Asolkar RN, Kondratyuk T, Pezzuto JM, Jensen PR and Fenical W (2007) Saliniketals A and B, bicyclic polyketides from the marine actinomycete Salinispora arenicola. J Nat Prod 70:83–88
Jensen PR, Williams PG, Oh DC, Zeigler L and Fenical W (2007) Species-specific secondary metabolite production in marine actinomycetes of the genus Salinispora. Appl Environ Microbiol 73:1146–1152
Bister B, Bischoff D, Strobele M, Riedlinger J, Reicke A, Wolter F, Bull AT, Zahner H, Fiedler HP and Sussmuth RD (2004) Abyssomicin C a polycyclic antibiotic from a marine Verrucosispora strain as an inhibitor of the p-aminobenzoic acid/tetrahydrofolate biosynthesis pathway. Chem Int Ed 43:2574–2576
Sujatha P, Bapi Raju KV and Ramana T (2005) Studies on a new marine Streptomycete BT 408 producing polyketide antibiotic SBR-22 effective against methicillin resistant Staphylococcus aureus. Microbiol Res. 160:119–126
Asolkar RN, Jensen PR, Kauffman CA and Fenical W (2006) Daryamides A-C weakly cytotoxic polyketides from a marine derived actinomycete of the genus Streptomyces strain CNQ-085. J Nat Prod 69:1756–1759
Cho JY, Kwon HC, Williams PG, Kauffman CA, Jensen PR and Fenical W (2006) Actinofuranones A and B, polyketides from a marine derived bacterium related to the genus Streptomyces (Actinomycetales). J Nat Prod 69:425–428
Kanoh K, Matsuo Y, Adachi K, Imagawa H, Nishizawa M and Shizuri Y (2005) Mechercharmycins A and B cytotoxic substances from marine derived Thermoactinomyces sp. YM 3-251. J Antibiot (Tokyo) 58:289–292
Romero F, Espliego F, Perez Baz J, Garcia de Quesada T, Gravalos D, de la Calle F and Fernandez Puentes JL (1997) Thiocoraline a new depsipeptide with antitumor activity produced by a marine Micromonospora. Taxonomy, fermentation isolation and biological activities. J Antibiot (Tokyo) 50:734–737
Renner MK, Shen YC, Cheng XC, Jensen PR, Frankmoelle W, Kauffman CA, Fenical W, Lobkovsky E and Cladry J (1999) Cyclomarins A-C, new anti inflammatory cyclic peptides produced by a marine bacterium (Streptomyces sp.). J Am Chem Soc 121:11273–11276
Miller ED, Kauffman CA, Jensen PR and Fenical W (2007) Piperazimycins cytotoxic hexadepsipeptides from a marine derived bacterium of the genus Streptomyces. J Org Chem 72:323–330
Lee HS, Shin HJ, Jang KH, Kim TS, Oh KB and Shin J (2005) Cyclic peptides of the Nocardamine class from a marine derived bacterium of the genus Streptomyces. J Nat Prod 68:623–625
Matsuo Y, Kanoh K, Yamori T, Kasai H, Katsuta A, Adachi K, Shin-Ya K and Shizuri Y (2007) Urukthapelstatin A, a novel cytotoxic substance from a marine derived Mechercharimyces asporophorigenes YM11-542. J Antibiot (Tokyo) 60:251–255
Moore BS, Trischman JA, Seng D, Kho D, Jensen PR and Fenical W (1999) Salinamides, anti-inflammatory depsipeptides from a marine Streptomycete. J Org Chem 64:1145–1150
Stritzke K, Schulz S, Laatsch H, Helmke E and Beil W (2004) Novel caprolactones from a marine Streptomycete. J Nat Prod 67:395–401
Li DH, Zhu TJ, Liu HB, Fanq YC, Gu OO and Zhu WM (2006) Four butenolides are novel cytotoxic compounds isolated from the marine derived bacterium, Streptoverticillium luteoverticillatum 11014. Arch Pharm Res 29:624–626
Malet Cascon L, Romero F, Espliego Vazquez F, Gravalos D and Fernandez Puentes JL (2003) IB00208, a new cytotoxic polycyclic xanthone produced by a marine derived Actinomadura. Isolation of the strain, taxonomy and biological activities. J Antibiot (Tokyo) 56:219–225
Hayakawa Y, Shirasaki S, Shiba S, Kawasaki T, Matsuo Y, Adachi K and Shizuri Y (2007) Piericidins C7 and C8, new cytotoxic antibiotics produced by a marine Streptomyces sp. J Antibiot (Tokyo) 60:196–200
Shiono Y, Shiono N, Seo S, Oka S and Yamazaki Y (2002) Effects of polyphenolic anthrone derivatives resistomycin and hypericin on apoptois in human megakaryoblastic leukemia CMK-7cell2. Natuforsch 57:923–929.
Adinaryan G, Venkateshan MR, Bpiraju VV, Sujatha P, Premkumar J, Ellaiah P and Zeeck A (2006) Cytotoxic compounds from the marine actinobacterium. Bio Org Khim 32:328–334
Kock I, Maskey RP, Biabani MAF, Helmke E and Laatsch H (2005) 1-hydroxy-1-norresistomycin and resistoflavine methyl ether new antibiotics from marine derived Streptomycetes. J Antibiot (Tokyo) 58:530–534
Gorajana A, MV, Vinjamuri S, Kurada BV, Peela S, Jangam P, Poluri E and Zeeck A (2006) Resistoflavine cytotoxic compound from a marine actinomycete, Streptomyces chibaensis AUBN(1)/7. Microbiol Res 29
Itoh T, Kinoshita M, Aoki S and Kobayashi M (2003) Komodoquinone A, a novel neuritogenic anthracycline from marine Streptomyces sp. KS3. J Nat Prod 66:1373–1377
Maskey RP, Helmke E and Laatsch H (2003) Himalomycin A and B isolation and structure elucidation of new fridamycin type antibiotics from a marine Streptomyces isolate. J Antibiot (Tokyo) 56:942–949
Asolkar RN, Schroder D, Heckmann R, Lang S, Dobler IW and Laatsch H (2004) Helquinoline, a new tetrahydroquinoline antibiotic from Janibacter limosus Hel1. J Antibiot (Tokyo) 57:17–23
Mercado IES, Davo AP, Jensen PR and Fenical W (2005) Antibiotic terpenoid chloro-dihydroquinones from a new marine actinomycete. J Nat Prod 68:904–910
Williams PG, Miller ED, Asolkar RN, Jensen PR and Fenical W (2007) Arenicolides A-C, 26 membered ring macrolides from the marine actinomycete Salinispora arenicola. J Org Chem 72:5025–5034
Kwon HC, Kauffman CA, Jensen PR and Fenical W (2006) Marinomycins A-D antitumor antibiotics of a new structure class from a marine actinomycete of the recently discovered genus “Marinispora”. J Am Chem Soc. 128:1622–32
Liu R, Zhu T, Li D, Gu J, Xia W, Fang Y, Liu H, Zhu W and Gu Q (2007) Two indolocarbazole alkaloids with apoptosis activity from a marine derived actinomycete Z2039-2. Arch Pharm Res 30:270–274
Schumacher RW, Talmage SC, Miller SA, Sarris KE, Davidson BS and Goldberg A (2003) Isolation and structure determination of an antimicrobial ester from a marine sediment derived bacterium. J Nat Prod 66: 1291–1293
Li F, Maskey RP, Qin S, Sattler I, Fiebig HH, Maier A, Zeeck A and Laatsch H (2005) Chinikomycins A and B Isolation, structure elucidation and biological activity of novel antibiotics from a marine Streptomyces sp. isolate MO45. J Nat Prod 68:349–353
Maskey RP, Helmke E, Kayser O, Fiebig HH, Maier A, Busche A and Laatsch H (2004) Anticancer and antibacterial trioxacarcins with high anti-malaria activity from a marine Streptomycete and their absolute stereochemistry. J Antibiot (Tokyo) 57:771–779
Jeong SY, Shin HJ, Kim TS, Lee HS, Park SK and Kim HM (2006) Streptokordin a new cytotoxic compound of the methylpyridine class from a marine derived Streptomyces sp. KORDI-3238. J Antibiot (Tokyo) 59:234–240
Feling RH et al. (2003) Salinosporamide A: a highly cytotoxic proteasome inhibitor from a novel microbial source, a marine bacterium of the new genus Salinispora. Angew Chem Int End Engl 42:355–357
Mitchell SS, Nicholson B, Teisan S, Lam KS and Potts BC (2004) Aureoverticillactam, a novel 22-atom macrocyclic lactam from the marine actinomycete Streptomyces aureoverticillatus. J Nat Prod 67:1400–1402
Imada C and Simidu U (1988) Isolation and characterization of an alpha amylase inhibitor producing actinomycete from marine environment. Nippon Suisan Gakkaishi 54: 1839–1845
Aoyama T, Kojima F, Imada C, Muraoka Y, Naqanawa H, Okami Y, Takeuchi T and Aoyaqi T (1995) Pyrostatins A and B, new inhibitors of N-acetyl-beta-D-glucosamidase, produced by Streptomyces sp. SA3501. J Enzyme Inhib 8:223–232
Aoyagi T, Hatsu M, Imada C, Naganawa H, Okami Y and Takeuchi T (1992) Pyrizinostatin: a new inhibitor of pyroglutamyl peptidase. J Antibiot (Tokyo) 45: 1795–1796
Wendt KU and Schulz GE (1998) Isoprenoid biosynthesis: manifold chemistry catalyzed by similar enzymes. Structure 6:127–133
Hoeksema H and Smith CG (1961) Novobiocin. Prog Ind Microbiol 3:91–139
Kuzuyama T and Seto H (2003) Diversity of the biosynthesis of the isoprene units. Nat Prod Rep 20:171–183
Uyeda M, Mizukami M, Yokomizo K and Suzuki K (2001) Pentalenolactone I and hygromycin A, immunosuppressants produced by Streptomyces filipinensis and Streptomyces hygroscopicus. Biosci Biotechnol Biochem 65:1252–1254
Shin-ya K, Shimizu S, Kunigami T, Furihata K, Furihata K and Seto H (1995) a new neuronal cell protecting substance, lavanduquinocin produced by Streptomyces viridochromogenes. J Antibiot (Tokyo) 48:574–578
Shiomi K, Iinuma H, Hamada M, Naganawa H, Manabe M, Matsuki C, Takeuchi T and Umezawa H (1986) Novel antibiotics napyradiomycins. Production, isolation, physico-chemical properties and biological activity. J Antibiot (Tokyo) 39:487–493
Nakajima M, Okazaki T, Iwado S, Kinoshita T and Haneishi T (1989) New diterpenoid antibiotics spirocardins A and B. J Antibiot (Tokyo) 42:1741–1748
Takahiro E, Yoshiro Y and Tadao K (1999) Synthetic study on radical scavenger benthocyanin A. Nippon Kagakkai Koen Yokoshu 76:774
Lee DG, Yoo ID and Kim WG (2007) Differential antiviral activity of benzastatin C and its dechlorinated derivative from Streptomyces nitrosporeus. Bio Pharm Bull 30:795–797
Shinya K, Kunigami T, Kim TS, Furihata K, Hayakawa Y and Seto H (1997) Carquinostatin B, a new neuronal cell protecting substance produced by Streptomyces exfoliatus. Biosci Biotechnol Biochem 61:1768–1769
Baizman Er, Branstrom AA, Longley CB, Allanson N, Sofia MJ, Gange D and Goldman RC (2000) Antibacterial activity of synthetic analogues based on the disaccharide structure of moenomycin an inhibitor of bacterial transglycosylase. Microbiology 146:3129–3140
Liras P and Martin JF (2006) Gene clusters for β-lactam antibiotics and control of their expression: why have clusters evolved, and from where did they originate. Int Microbiol 9:9–19
Ghanem NB, Sabry SA, El-Sherif ZM and Abu El-Ela GA (2000) Isolation and enumeration of marine actinomycetes from seawater and sediments in Alexandria. J Gen Appl Microbiol 46:105–111
Jensen PR, Gontang E, Mafnas C, Mincer TJ and Fenical W (2005) Culturable marine actinomycete diversity from tropical Pacific ocean sediments. Environ Microbiol 7:1039–1048
Pisano MA, Sommer JA and Branacaccio L (2004) Isolation of bioactive actinomycetes from marine sediments using rifampicin. Appl Microbiol Biotechnol 31:609–612
Gillespie DE et al. (2002) Isolation of antibiotics turbomycin A and B from a metagenomic library of soil microbial DNA. Appl Environ Microbiol 68:4301–4306
Brady SF, Chao CJ and Clardy J (2004) Long chain N-acyltyrosine synthases from environmental DNA. Appl Environ Microbiol 70:6865–6870
Schmeisser C, Steele H and Streit WR (2007) Metagenomics, biotechnology with non-culturable microbes. Appl Microbiol Biotechnol 75:955–962
Sharma R, Ranjan R, Kapardar RK and Grover A (2005) Unculturable bacterial diversity: an untapped resource. Curr Sci 89:72–77
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Solanki, R., Khanna, M. & Lal, R. Bioactive compounds from marine actinomycetes. Indian J Microbiol 48, 410–431 (2008). https://doi.org/10.1007/s12088-008-0052-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12088-008-0052-z